Venous thromboembolic disease in patients with lung cancer

Abstract

Introduction: Thromboembolic disease encompasses two major entities that are deep vein thrombosis and pulmonary thromboembolism together constitute the second leading cause of death in cancer patients and sometimes the first manifestation of underlying hidden neoplasm. It occurs most frequently in stomach, pancreas, gynecological, bladder, testicle and lung tumors, where it appears in up to 14% of cases and can increase further with treatment. For its management it is recommended to evaluate the risk and subsequently the use of low molecular weight heparins, although other options can be used. Objective: to explain the epidemiological ant pathophysiological elements and the treatment of thromboembolic disease in patients with lung cancer. Methodology: A review and analysis of the bibliography was carried out, detailing incidence, etiology in cancer patients and main management options. Conclusions: Its proper diagnosis and timely management will ensure for patients a better quality of life and greater overall survival, and for hospital institutions a reduction in significant expenditures.